Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Glycine-Histidine-Lysine (GHK) Alleviates Astrocytes Injury of Intracerebral Hemorrhage via the Akt/miR-146a-3p/AQP4 Pathway
An important link with carnitine derives from chronic hepatitis B patients
The pharmaceutical formulation has FDA approval for HIV-associated lipodystrophy under the brand name Egrifta
Phase 2 clinical trial data published in the New England Journal of Medicine (Jastreboff et al., 2023) demonstrated mean body weight reductions of up to approximately 24% over 48 weeks in adults with obesity a notable finding, though long-term durability data and head-to-head comparisons with other treatments are not yet available
This temporal data underpins the research design rationale for PEG-MGFs extended half-life: it must be present during the acute 024-hour MGF signalling window and maintained through the proliferative phase
US$ 29.30
US$ 25.55
US$ 29.67
US$ 28.61
US$ 26.39
